Whistleblowers allege problems with Wyeth's Prevnar

Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers' whistleblower suits accused the company of making false statements to the government concerning manufacturing problems with the vaccine.

Anthony Sokol, a manufacturing scientist, says he was fired after raising concerns regarding the vaccine and that Wyeth had concealed and misrepresented the data it gave to the government. Sokol's suit alleges he was fired in 2005. Prevnar earned $2.4 billion in sales last year.

- read the report from the Wall Street Journal

Related Article:
Pharma execs practice positive thinking. Report

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.